Paper8221978
Nematocidal activity of turmeric: synergistic action of curcuminoids.
Kiuchi F and 5 others. Chem Pharm Bull (Tokyo), 1993. Cited by 132 papers, by iCite.
Cite this record
ConductScience Library. Nematocidal activity of turmeric: synergistic action of curcuminoids. Papers, record 8221978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8221978
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antinematodal Agents | Major topic |
| Curcumin | Major topic |
| Spices | Major topic |
| Animals | |
| Drug Synergism | |
| Toxocara canis |
Source PubMed
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42446543 | Chemical constituents in the rhizome of Curcuma longa and the pharmacological importance of curcumin hybrids. | Med Chem Res | 2026 | https://conductscience.org/library/papers/42446543 | PubMed |
| 41020838 | Revisiting Curcumin in Cancer Therapy: Recent Insights into Molecular Mechanisms, Nanoformulations, and Synergistic Combinations. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41020838 | PubMed |
| 40437595 | Curcuma Longa (turmeric): from traditional applications to modern plant medicine research hotspots. | Chin Med | 2025 | https://conductscience.org/library/papers/40437595 | PubMed |
| 38611731 | Cyclocurcumin as Promising Bioactive Natural Compound: An Overview. | Molecules | 2024 | https://conductscience.org/library/papers/38611731 | PubMed |
| 37959661 | Effects of Roasting Conditions on Antibacterial Properties of Vietnamese Turmeric (Curcuma longa) Rhizomes. | Molecules | 2023 | https://conductscience.org/library/papers/37959661 | PubMed |
| 35163854 | Elucidation of Chemical Interactions between Crude Drugs Using Quantitative Thin-Layer Chromatography Analysis. | Molecules | 2022 | https://conductscience.org/library/papers/35163854 | PubMed |
| 34768818 | Monocarbonyl Analogs of Curcumin Based on the Pseudopelletierine Scaffold: Synthesis and Anti-Inflammatory Activity. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34768818 | PubMed |
| 34659641 | Effects of Curcumin Supplementation on Inflammatory Markers, Muscle Damage, and Sports Performance during Acute Physical Exercise in Sedentary Individuals. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34659641 | PubMed |
| 33953873 | Molecular effects of curcumin on the experimental autoimmune encephalomyelitis. | Vet Res Forum | 2021 | https://conductscience.org/library/papers/33953873 | PubMed |
| 33553036 | The assessment of antidiabetic properties of novel synthetic curcumin analogues: α-amylase and α-glucosidase as the target enzymes. | J Diabetes Metab Disord | 2020 | https://conductscience.org/library/papers/33553036 | PubMed |
| 32961786 | Does Curcumin Have a Role in the Interaction between Gut Microbiota and Schistosoma mansoni in Mice? | Pathogens | 2020 | https://conductscience.org/library/papers/32961786 | PubMed |
| 32927725 | Obstacles against the Marketing of Curcumin as a Drug. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32927725 | PubMed |
| 32361773 | Effects of turmeric extract supplementation on inflammation and muscle damage after a half-marathon race: a randomized, double-blind, placebo-controlled trial. | Eur J Appl Physiol | 2020 | https://conductscience.org/library/papers/32361773 | PubMed |
| 32081619 | A sensitive LC-MS assay using derivatization with boron trifluoride to quantify curcuminoids in biological samples. | Anal Biochem | 2020 | https://conductscience.org/library/papers/32081619 | PubMed |
| 31878265 | Curcumin Alleviates IUGR Jejunum Damage by Increasing Antioxidant Capacity through Nrf2/Keap1 Pathway in Growing Pigs. | Animals (Basel) | 2019 | https://conductscience.org/library/papers/31878265 | PubMed |
| 31432177 | Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR pathways. | Oncol Rep | 2019 | https://conductscience.org/library/papers/31432177 | PubMed |
| 31083285 | Geographical Discrimination in Curcuminoids Content of Turmeric Assessed by Rapid UPLC-DAD Validated Analytical Method. | Molecules | 2019 | https://conductscience.org/library/papers/31083285 | PubMed |
| 29209088 | Inhibitory effects of curcumin and cyclocurcumin in 1-methyl-4-phenylpyridinium (MPP+) induced neurotoxicity in differentiated PC12 cells. | Sci Rep | 2017 | https://conductscience.org/library/papers/29209088 | PubMed |
| 28856444 | Mechanisms of curcumin-induced gastroprotection against ethanol-induced gastric mucosal lesions. | J Gastroenterol | 2018 | https://conductscience.org/library/papers/28856444 | PubMed |
| 28579928 | Single cell amperometry reveals curcuminoids modulate the release of neurotransmitters during exocytosis from PC12 cells. | J Electroanal Chem (Lausanne) | 2016 | https://conductscience.org/library/papers/28579928 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8221978
GET https://conductscience.org/api/papers/v1/8221978/cited_by?page=2